Is ENDRA Life Sciences Inc (NDRA) overvalued? · P/E 0.0, $2.6M cap
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
This page asks whether ENDRA Life Sciences Inc (NDRA) looks expensive on cached numbers — not a short thesis.
No cached income statement for NDRA, so there is no earnings base to call rich or cheap.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NDRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NDRA stock page for the full model, not this heading.
Not investment advice.